{"ModuleTitle": "Company Description", "CompanyName": "DURECT Corporation", "Symbol": "DRRX", "Address": "10260 BUBB RD, CUPERTINO, California, 95014, United States of America", "Phone": "4087771417", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We are a biopharmaceutical company with research and development programs\r\nbroadly falling into two categories: (i) new chemical entities derived from our\r\nEpigenetic Regulator Program, in which we attempt to discover and develop\r\nmolecules which have not previously been approved and marketed as therapeutics,\r\nand (ii) proprietary pharmaceutical programs, in which we apply our formulation\r\nexpertise and technologies largely to active pharmaceutical ingredients whose\r\nsafety and efficacy have previously been established but which we aim to improve\r\nin some manner through a new formulation. We also manufacture and sell osmotic\r\npumps used in laboratory research, design, develop and manufacture a wide range\r\nof standard and custom biodegradable polymers and excipients for pharmaceutical\r\nand medical device clients for use as raw materials in their products.\r\n\r\nOur product pipeline currently consists of multiple investigational drug\r\ncandidates in development.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f05%2f0001564590-20-008923.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "David J. Ellis", "title": "Vice President-Clinical Development"}, {"name": "James E. Brown", "title": "President, Chief Executive Officer & Director"}, {"name": "Judy R. Joice", "title": "Senior VP-Operations & Corporate Quality Assurance"}, {"name": "Michael H. Arenberg", "title": "Chief Financial Officer & Secretary"}, {"name": "Wei Qi Lin", "title": "Executive Vice President-Research & Development"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}